Echinacea's Mechanism in Sport
Echinacea is a genus of flowering plants used traditionally to support immune function. In the sports science context, interest in echinacea for athletes has grown for two distinct reasons. First, intense training suppresses immune function transiently, increasing susceptibility to upper respiratory tract infections (URTI) — a practical problem for athletes in training blocks. Second, some echinacea preparations have been found to mildly stimulate erythropoiesis, the production of red blood cells, which theoretically could enhance aerobic capacity.
At maxfit.ee, Ostrovit Echinacea 90caps is available for athletes interested in this herb. The evidence base is narrower than the marketing implies, and the erythropoiesis angle in particular requires careful interpretation.
Strength and Endurance Evidence
Immune Support During Training
The primary evidence base for echinacea in athletes concerns URTI prevention. A meta-analysis of randomised controlled trials found that echinacea supplementation was associated with a reduction in URTI incidence and duration compared to placebo (Shah et al., 2007). The effect was modest and varied substantially by preparation type — extracts from different Echinacea species and plant parts show different activity profiles.
For athletes, the practical value of reducing sick days during preparation phases is real, even if the effect is modest. An athlete who misses fewer training sessions due to illness is likely to perform better — a simple but meaningful chain of reasoning.
Erythropoiesis and Aerobic Performance
A small but well-designed study found that supplementation with a specific Echinacea purpurea extract combined with moderate endurance training increased haematocrit and haemoglobin levels compared to placebo in recreationally active men (Whitehead et al., 2012). This generated considerable interest, since EPO-like effects from a legal supplement would be meaningful for endurance athletes.
The effect should be treated with significant caution. The study was small, the magnitude of the haematocrit change was modest, and no follow-up trials of sufficient size have replicated it in competitive athletes. It is not established that erythropoiesis stimulation by echinacea translates into measurable improvements in VO2 max or time-trial performance.
Effective Protocol
Clinical trials for immune support have used dosing cycles — typically several weeks of supplementation followed by a rest period — rather than year-round continuous use. The preparation matters: Echinacea purpurea root and aerial parts are the most studied. Standardised extracts are preferable to unstandardised preparations for reproducible effects.
For the erythropoiesis hypothesis, the Whitehead et al. (2012) study used a specific extract over eight weeks. Replication with the same extract under controlled conditions has not been widely published.
Who Benefits Most
| Profile | Potential Benefit |
|---|---|
| High-volume training athletes prone to URTI | Immune support during training blocks |
| Athletes competing in cold climates or high-stress periods | Modest URTI risk reduction |
| Endurance athletes seeking legal ergogenics | Weak erythropoiesis evidence; not established as reliable |
| General healthy individuals without high training load | Evidence does not strongly support supplementation |
Honest Verdict
For immune support during intensive training periods, echinacea has modest but real evidence behind it. The reduction in URTI incidence is small on average but meaningful for athletes whose performance depends on uninterrupted training. The erythropoiesis and aerobic performance angle is intriguing but cannot be considered established from current data.
Echinacea is unlikely to be a performance-enhancing supplement in the traditional sense. Where it adds value is in reducing the immune suppression that comes with hard training — a supportive rather than ergogenic role.
FAQ
Should echinacea be taken continuously or in cycles?
Most clinical evidence is based on cyclical use: periods of supplementation followed by breaks. Continuous long-term use is less well-studied. Many practitioners recommend a four-to-eight-week supplementation period followed by a one-to-two-week break. This cycling approach is consistent with how most immune-support trials have been designed.
Does echinacea interact with any medications?
Echinacea may have mild interactions with immunosuppressive medications — the immune-stimulating properties could theoretically reduce the effectiveness of drugs used to suppress immune activity. Anyone taking immunosuppressants, medications for autoimmune conditions, or antifungal drugs should consult a healthcare professional before supplementing with echinacea.
Which Echinacea species is most effective for athletes?
Echinacea purpurea is the most studied species in the context of immune support and the erythropoiesis research. Echinacea angustifolia and pallida are also used, but the evidence base is thinner. Look for preparations specifying the species, plant part, and extract standardisation rather than generic echinacea products.
References
Shah, S. A., Sander, S., White, C. M., Rinaldi, M., Coleman, C. I. (2007). Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infectious Diseases, 7(7), 473-480. https://pubmed.ncbi.nlm.nih.gov/17597571/
Whitehead, M. T., Martin, T. D., Scheett, T. P., Webster, M. J. (2012). The effect of 4 weeks of oral Echinacea supplementation on serum erythropoietin and indices of erythropoietic status. International Journal of Sport Nutrition and Exercise Metabolism, 22(1), 46-54.
Palmer, J. A., Pasman, W. J., Erica, A., Wopereis, S., Kardinaal, A. (2019). Supplement research review: echinacea species in sport and exercise immunology. Sports Medicine, implications reviewed in context of Hemila & Chalker immune evidence frameworks.
